Free lookups: 0/3 Unlock Pro
Clinical reference Find a medicine
Ctrl K
0 of 3 free lookups remaining Upgrade
New search Medicine profile Folic acid

Clinical medicine profile

Folic acid

Vitamin C [EPC], Nicotinic Acid [EPC]

OTC
Evidence state Source-linked Review date not recorded
Route
ORAL / IM / IV (selected)
Schedule
OTC
ATC
Not assigned
PPB status
registered
Patient advice Check interactions
01 Risk first

Safety essentials

The information most likely to change a prescribing or dispensing decision.

Contraindications

  • CONTRAINDICATIONS: Integra FTM is contraindicated in patients with known hypersensitivity to any of its ingredients
  • also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias.
  • Pernicious anemia is a contraindication, as folic acid may obscure its signs and symptoms.

Precautions

  • WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6.
  • Keep this product out of reach of children.
  • In case of accidental overdose, call a doctor or poison control center immediately.
  • WARNING: Folic acid alone is improper therapy in the treatment for pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient.
  • PRECAUTIONS: General: Anemia is a manifestation that requires appropriate investigation to determine its cause or causes.
  • No single regimen fits all cases and the status of the patient observed in follow-up is the final criterion for adequacy of therapy.
  • Periodic clinical and laboratory studies are considered essential.
  • Blood examinations including hemoglobin and hematacrit should be done at the usual intervals to make certain that therapy is adequate.
  • Use with care in the presence of peptic ulcer, regional enteritis, and ulcerative colitis.
  • Folic acid, especially in doses above 0.1 mg -0.4 mg daily may obscure pernicious anemia, in that hematological remission can occur while neurological manifestations remain progressive.
02 Point of care

Dosing matrix

Population and organ-function guidance, shown together for faster comparison.

Adult

DOSAGE AND ADMINISTRATION: Adults (persons over 12 years of age), One (1) capsule daily, between meals, or as prescribed by a physician. Do not exceed recommended dosage. Do not administer to children under the age of 12.

Paediatric

Pediatric Use: Safety and effectiveness of this product have not been established in pediatric patients.

Renal

None usually.

  • CrCl 0–120: Standard preventive/treatment doses.
Hepatic

None usually.

03 Clinical use

Use, effects & interactions

Indications

  • INDICATIONS: Integra FTM is indicated for the treatment of iron deficiency anemia, and folate deficiency anemia.
  • Integra FTM is indicated in pregnancy for the prevention and treatment of iron deficiency and to supply a maintenance dosage of folic acid.

Adverse effects

  • Adverse Reactions: Folic Acid: Allergic sensitizations have been reported following both oral and parenteral administration of folic acid.
  • Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation, heartburn and vomiting) occur occasionally, but are usually mild and may subside with continuation of therapy.
  • Reducing the dose and administering it with meals will minimize these effects in the sensitive patient.
  • Increasing fiber in the diet can relieve constipation.
  • Iron may turn stools black.
  • This is a harmless effect that is a result of unabsorbed iron.
  • Although the absorption of iron is best when taken between meals, giving Integra FTM after meals may control occasional G.I. disturbances.
  • Integra FTM is best absorbed when taken at bedtime.
  • Prefer food-first then targeted replacement.
  • Document laboratory indication for high-dose therapy.
  • Public health: vitamin A, iron, folate programmes per MoH guidance.
04 Pharmacology

Mechanism & disposition

It acts on megaloblastic bone marrow to produce a normoblastic marrow.

It acts on megaloblastic bone marrow to pr…Vitamins and minerals act as cofactors, an…Pharmacological high-dose effects differ f…
Read complete mechanism

It acts on megaloblastic bone marrow to produce a normoblastic marrow. Vitamins and minerals act as cofactors, antioxidants, structural elements or hormone precursors (e.g. vitamin D endocrine axis). Pharmacological high-dose effects differ from nutritional repletion.

Onset

Haematologic response days–weeks

Duration

While deficient / prevention ongoing

Route

ORAL / IM / IV (selected)

Absorption

of the ferrous iron by the bloodstream. However, the iron available from PIC is absorbed in the lower gut, via an active protein transport mechanism".

05 Special populations

Pregnancy, lactation & diet

Pregnancy

USAGE IN PREGNANCY: Before Integra FTM is prescribed for megaloblastic anemia in pregnancy, appropriate diagnostic exclusion of Addisonian pernicious anemia, (due to faulty or blocked absorption of vitamin B12, or extrinsic factor or either a genetic, immunological or surgical basis) should be carried out.

Lactation

Maternal repletion often appropriate; avoid megadoses.

06 Kenya market

Brands & loaded prices

FromKES 35
MedianKES 35
Listings1
BrandManufacturerPackObserved price
FOLISURE Not recorded 5MG 100*S KES 35.48Daima Chemist price-list reference ↗ Source date not recorded · verify current price
07 Provenance

Sources & review state

Primary sourceLocal active-ingredient clinical extract; FDA drug label via OpenFDA/DailyMed; WHO nutrition / haematology consensus (batch 1); Professional class pharmacology (Vitamin / mineral / nutritional supplement)
Last reviewedNot recorded
EvidenceSource-linked
Open source document ↗

Decision support only. Confirm patient-specific decisions against the current product SmPC, Kenya STG/EML, and professional judgement.